J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

Medically reviewed by Marla Anderson, MD Metastatic prostate cancer is also referred to as stage 4 or advanced prostate cancer. It's cancer that began in the prostate, a gland located under the ...

The CDC says prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. With prostate ...

The American Urological Association recommends baseline PSA screening for average-risk men starting at age 45.

In reality, most prostate cancers are detected through routine screening, typically with a simple blood test. Experts ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

To close out Men’s Health Month, the Cancer Connections team sat down with Dr. William Dahut, the American Cancer Society’s ...

I am a healthy 89-year-old United States Army veteran. In August 2017, I was diagnosed with advanced prostate cancer and was ...

Australians in their 30s and 40s are being diagnosed with cancer at unprecedented rates, with at least 10 types of the ...

Prostate cancer is a significant health concern for men worldwide, with increasing diagnoses and fatalities projected. Early ...

Researchers explored a compelling new angle on the use of rectal spacers during prostate cancer radiotherapy, and emerging evidence suggests their benefits may extend further.